Testing a New Drug for Hard-to-Control Asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with asthma for at least 12 months
- You take medium-to-high dose inhaled steroid plus another asthma controller medication, with a stable dose for at least 4 weeks
- You have had at least one asthma attack in the past 12 months despite being on asthma medications
- Your lung function tests show specific results (FEV1 between 40% and 80% of predicted, and reversibility after using a rescue inhaler)
- You do not smoke currently and have never been a heavy smoker (less than 10 pack-years)
- You are willing to use an electronic diary device with at least 80% compliance and complete required lung function tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called GB-0895 for people with severe asthma that is not well controlled by current treatments. The medicine is added to your usual asthma medications to see if it can reduce asthma attacks and improve breathing.
This study tests a new add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this medicine can reduce asthma attacks and improve breathing.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.